Cited by

• The Role of Cyanidin-3-O-glucoside in Modulating Oxaliplatin Resistance by Reversing Mesenchymal Phenotype in Colorectal Cancer.

  Kurter H, Basbinar Y, Ellidokuz H, Calibasi-Kocal G. Kurter H, et al. Nutrients. 2023 Nov 7;15(22):4705. doi: 10.3390/nu15224705. Nutrients. 2023. PMID: 38004099 Free PMC article.
• Patient's attitudes and perceptions around attending oncology consultations following surgery for colorectal cancer: A qualitative study.

  Moodley Y, Bhadree S, Stopforth L, Kader S, Wexner S, van Wyk J, Neugut A, Kiran R. Moodley Y, et al. F1000Res. 2023 Jun 19;12:698. doi: 10.12688/f1000research.134816.1. eCollection 2023. F1000Res. 2023. PMID: 38173827 Free PMC article.
• A Novel B7-H6-Targeted IgG-Like T Cell-Engaging Antibody for the Treatment of Gastrointestinal Tumors.

  Zhang W, Auguste A, Liao X, Walterskirchen C, Bauer K, Lin YH, Yang L, Sayedian F, Fabits M, Bergmann M, Binder C, Corrales L, Vogt AB, Hudson LJ, Barnes MP, Bisht A, Giragossian C, Voynov V, Adam PJ, Hipp S. Zhang W, et al. Clin Cancer Res. 2022 Dec 1;28(23):5190-5201. doi: 10.1158/1078-0432.CCR-22-2108. Clin Cancer Res. 2022. PMID: 36166004 Free PMC article.
• Spheroids and organoids derived from colorectal cancer as tools for in vitro drug screening.

  Ahmad Zawawi SS, Salleh EA, Musa M. Ahmad Zawawi SS, et al. Explor Target Antitumor Ther. 2024;5(2):409-431. doi: 10.37349/etat.2024.00226. Epub 2024 Apr 25. Explor Target Antitumor Ther. 2024. PMID: 38745769 Free PMC article. Review.
• FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells.

  Ramzy GM, Boschung L, Koessler T, Delucinge-Vivier C, Docquier M, McKee TA, Rubbia-Brandt L, Nowak-Sliwinska P. Ramzy GM, et al. Cancers (Basel). 2022 Sep 30;14(19):4812. doi: 10.3390/cancers14194812. Cancers (Basel). 2022. PMID: 36230735 Free PMC article.